Clinical Trial Update: The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial [Phase 3]

View source ↗

Summary

A Phase 3 multicenter randomized trial examining higher protein dosing in critically ill patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Frailty
• Malnutrition
• Nutritional Disorder
• Sarcopenia

Snippet

Sponsor: RWTH Aachen University | Conditions: Nutritional Disorder, Critical Illness | Phase 3 | Status: WITHDRAWN